Reiteration Archives - Page 29 of 399

2 minute read

Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future

April 17, 3:37 PM

Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims to lead in Innovative Medicines and MedTech.

JNJ

2 minute read

Broadcom’s AI Chips Forge Ahead Unlocking Billions in Tech Potential, Analysts Say

By Anusuya Lahiri

April 17, 2:55 PM

Piper Sandler analyst reiterated Overweight rating on Broadcom with $1,650 target. AVGO is a top player in generative AI computing. Companies are hesitant to adopt, but management is confident in $50B opportunity. AVGO 1-1.5 years ahead of competition in Switch Products.

AVGO

2 minute read

Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick

By Vandana Singh

April 17, 2:39 PM

Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300 cells/μL.

AMGN

2 minute read

Meta’s Strategic AI Investments Enhance Ad Targeting, Boosting Revenue Projections: Analyst

By Anusuya Lahiri

April 17, 2:37 PM

Truist Securities analyst Youssef Squali maintained a Buy rating for Meta Platforms Inc and raised its price target. He expects strong revenue and earnings growth due to improved monetization and AI initiatives.

FCOM

2 minute read

Bank Of America Loan Growth Is Better Than Peers, Analysts Predict ‘Good Core Operating Leverage’

By Benzinga Newsdesk

April 17, 12:46 PM

Bank of America's results benefited from markets-related revenues; expects "good core operating leverage for the next three quarters."

BAC

3 minute read

Tesla Analyst Says Expect ‘Fireworks’ Into Shareholder Meeting After EV Giant’s Proxy Filing: ‘Clock Has Struck Midnight For Musk’

By Shanthi Rexaline

April 17, 10:43 AM

Tesla is facing challenging near term amid multiple headwinds the company faces but Musk can make a difference, says Daniel Ives.

TSLA

3 minute read

Why This Tesla Bull Remains Stubbornly Optimistic About EV Giant Amid Cloud Of Doubts: ‘Every Headline Is Either World-Ending Or World-Beating…’

By Shanthi Rexaline

April 17, 4:51 AM

Stating that he is taking a balanced view, the analyst said the first-quarter deliveries miss was not only demand-driven but also supply-driven.

TSLA

4 minute read

Netflix Q1 Earnings Preview: Subscriber Growth, Potential Price Increase, Ad-Tier Plan And More On What Wall Street Expects

By Chris Katje

April 16, 2:38 PM

Netflix stock is in the spotlight for the week with imminent first quarter financial results. Analysts are looking at subscriber adds and a potential price increase as the key headline items.

NFLX

2 minute read

Google’s Growth Ignited by AI and Premium Video Ads, Analyst Predicts Brighter Future

By Anusuya Lahiri

April 16, 2:19 PM

Stifel analyst maintains Buy rating for Alphabet (GOOGL) and raises price target to $174. Google's strong AI and advertising initiatives support long-term growth. Competitive threat overdone. YouTube TV a top platform. GOOGL shares traded at $154.42.

GOOG

2 minute read

What’s Going On With AMD Stock Tuesday?

By Anusuya Lahiri

April 16, 2:11 PM

AMD announced new Ryzen PRO 8040 Series for business laptops and mobile workstations and Ryzen PRO 8000 Series AI-enabled desktop processor. AI PC shipments expected to account for 22% by 2024. Multiple analysts maintain AMD as top pick, with HSBC upgrading to Buy and $225 price target.

AMD